From 7% to 10% of all retinoblastomas and from 44% to 71% of familial retinoblastomas in
developed countries are diagnosed in the neonatal period, usually through pre-or post-natal …

Purpose To compare overall outcomes of conventional postnatal screening of familial
retinoblastoma and prenatal RB1 mutation identification followed by planned early-term …

Simple Summary Offspring of patients with heritable retinoblastoma have a high risk of
developing retinoblastoma themselves. Ophthalmological screening from birth in at-risk …

The aim of the present study was to investigate the expression of microRNA (miR)‑338‑5p in
retinoblastoma (RB), thereby evaluating whether it could have potential as a biomarker to …

Background Fetal deformity is a disease caused by abnormal chromosome structure, which
may be influenced by genetic factors as well as the maternal and external environment …

Objectives To analyse the profile and implication of genetic testing in a cohort of
retinoblastoma (RB) patients and their families conducted on a single day during World …

BACKGROUND microRNA (miRNA) molecules are considered as biomarkers and have
promising future for early‐stage cancer diagnosis. Lawsone (Law) enriched carbon …

Background Prevention of genetic disorders in the family is gaining significance because of
the burden of these untreatable and devastating disorders. Sir Ganga Ram Hospital (SGRH) …

Introduction: Persistent hyperplastic primary vitreous (PHPV) involves a spectrum of
congenital ocular abnormalities characterized by the presence of a vascular membrane …

Retinoblastoma (RB) is the most common primary intraocular malignant tumor in infants and
the prototype of human hereditary tumors. Its occurrence and development are closely …